Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis
Titel:
Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis
Auteur:
Roversi, Fernanda Marconi Pericole, Fernando Vieira Machado-Neto, João Agostinho da Silva Santos Duarte, Adriana Longhini, Ana Leda Corrocher, Flávia Adolfo Palodetto, Bruna Ferro, Karla Priscila Rosa, Renata Giardini Baratti, Mariana Ozello Verjovski-Almeida, Sergio Traina, Fabiola Molinari, Alessio Botta, Maurizio Saad, Sara Teresinha Olalla
Verschenen in:
Biochimica et Biophysica Acta. Molecular basis of disease